戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ascular endothelial growth factor) and PDGF (platelet derived growth factor).
2 ristics when exposed to cholesterol or PDGF (platelet-derived growth factor).
3 ascular endothelial growth factor (VEGF) and platelet-derived growth factor.
4 wing stimulation with interleukin-1alpha and platelet-derived growth factor.
5  CCN2 (connective tissue growth factor), and platelet-derived growth factor.
6  and PKM2 oxidation in cells stimulated with platelet-derived growth factor.
7 rbor an activating mutation in either KIT or platelet-derived growth factor A ( PDGFRA).
8 r receptor alpha (PDGFRalpha) and its ligand platelet-derived growth factor A (PDGF-A) are co-express
9                                 In addition, platelet-derived growth factor A (PDGFA) was overexpress
10 n activating gene mutations in either KIT or platelet-derived growth factor A (PDGFRA).
11              The membrane-bound receptor for platelet-derived growth factor A (PDGFRalpha) is crucial
12 ast differentiation through the secretion of platelet-derived growth factor AA (PDGF-AA).
13 s (angiopoietin 2; hepatocyte growth factor; platelet-derived growth factor AA and BB; placental grow
14                    Intravitreal injection of platelet-derived growth factor -AA or -AB led to profoun
15                                      Ectopic platelet-derived growth factor-AA (PDGF-AA) protein indu
16 broblasts exhibit impaired responsiveness to platelet-derived growth factor-AA and sonic hedgehog, tw
17 rotrophic factor, fibroblast growth factors, platelet-derived growth factor-AA, vascular endothelial
18  [TGF-beta1], epidermal growth factor [EGF], platelet-derived growth factor AB [PDGF-AB], and albumin
19 tor, vascular endothelial growth factor, and platelet-derived growth factor AB) before and after comp
20 line lung/liver SUVmax index correlated with platelet-derived growth factor AB.
21 e Boyden chamber and show that a gradient of platelet-derived growth factor-AB (PDGF-AB) expedites mi
22 sient treatment with AZA in combination with platelet-derived growth factor-AB converts primary somat
23                        These cells expressed platelet-derived growth factor alpha and high transcript
24  1, and transiently suppressed myofibroblast platelet-derived growth factor alpha differentiation mar
25 a similar level of TNF-alpha, TGF-beta1, and platelet-derived growth factor alpha genes, and a high l
26 cts with HEUS and in untreated subjects with platelet-derived growth factor alpha-negative HES (n = 2
27       Platelet-rich plasma (PRP) consists of platelet-derived growth factor and transforming growth f
28  proteins (four antibodies and the chemokine platelet-derived growth factor) and two monovalent prote
29 d non-responders including stem cell factor, platelet-derived growth factor, and interleukin-15.
30 flammatory cytokines, invade Matrigel toward platelet-derived growth factor, and resist hypoxia-induc
31 th factors, such as epidermal growth factor, platelet-derived growth factor, and Wnt; and hormones, s
32 o mediate the secretion of Pvf, a ligand for platelet-derived growth factor- and vascular endothelial
33 ice, including interleukin-1beta (IL-1beta), platelet-derived growth factor, angiopoietin 2, insulin-
34 ading frame, under the influence of a 1.5 kb platelet derived growth factor B (PDGFB) promoter.
35                                      Because platelet-derived growth factor B (PDGF-B) signaling has
36  morphogen sonic hedgehog (Shh) is driven by platelet-derived growth factor B (PDGF-BB) in vascular s
37 , myogenesis regulating glycosidase (MYORG), platelet-derived growth factor B (PDGFB) and platelet-de
38                                              Platelet-derived growth factor B (PDGFB) plays a crucial
39 ar endothelial growth factor A (VEGF-A), and platelet-derived growth factor B chain (PDGF-BB), to sti
40 expression of vascular endothelial cadherin, platelet-derived growth factor B, S1P(1), and CCN1 (mole
41 nd AKT and compared them to oligodendroglial platelet-derived growth factor B-induced tumors in Ctv-a
42 r receptor in mice bearing RCAS/tv-a-induced platelet-derived growth factor B-overexpressing glioblas
43  modification of pericyte coverage involving platelet-derived growth factor B.
44 h, we demonstrate that two of these pathways-platelet-derived growth factor BB (PDGF BB) and neural p
45       We first identified Shh as a target of platelet-derived growth factor BB (PDGF-BB) and found th
46 ed a fibronectin peptide (P12) that can bind platelet-derived growth factor BB (PDGF-BB) and promote
47                      Growth factors, such as platelet-derived growth factor BB (PDGF-BB) and transfor
48 ulated by ECFC-derived paracrine factors via platelet-derived growth factor BB (PDGF-BB)/platelet-der
49  study participants, the angiogenic cytokine platelet-derived growth factor BB glycoprotein correlate
50            Two weeks after AMI, increased PB platelet-derived growth factor BB glycoprotein was assoc
51 sely, PCSK6 overexpression increased PDGFBB (platelet-derived growth factor BB)-induced cell prolifer
52 henotype was hyperproliferative to serum and platelet-derived growth factor BB, and unresponsive to t
53 lated with IL (interleukin)-1alpha and PDGF (platelet-derived growth factor)-BB with SMILR knockdown
54  present study was to evaluate the levels of platelet derived growth factor-BB (PDGF-BB) in gingival
55 ession of the spliced XBP1 or treatment with platelet derived growth factor-BB up-regulated miR-150 e
56 tors such as tumor necrosis factor-alpha and platelet derived growth factor-BB were also found to inc
57 sed approach is shown here to work with both platelet-derived growth factor-BB (PDGF-BB) and vascular
58 ), which when tethered to a surface acted as platelet-derived growth factor-BB (PDGF-BB) enhancers to
59                          Here, we found that platelet-derived growth factor-BB (PDGF-BB) secreted by
60 lar endothelial growth factor-A (VEGF-A) and platelet-derived growth factor-BB (PDGF-BB) that were en
61 sforming growth factor-alpha (TGF-alpha) and platelet-derived growth factor-BB (PDGF-BB) were reduced
62 helial growth factor-A (VEGF-A) isoforms and platelet-derived growth factor-BB (PDGF-BB), mainly thro
63  the receptor tyrosine kinase (RTK) agonist, platelet-derived growth factor-BB (PDGF-BB)-induced p21C
64 rom the culture of fat with ROS or PGZ on i) platelet-derived growth factor-BB (PDGF-BB)-stimulated p
65  (C-MEMS) was developed for the detection of platelet-derived growth factor-BB (PDGF-BB).
66 lar endothelial growth factor A (VEGF-A) and platelet-derived growth factor-BB (PDGF-BB).
67 atrix derivative (EMD) and recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with beta-
68 e graft (CTG) (control) or recombinant human platelet-derived growth factor-BB + beta-tricalcium phos
69 tor-2, transforming growth factor-beta1, and platelet-derived growth factor-BB at 2 weeks compared wi
70 gration and fibronectin synthesis induced by platelet-derived growth factor-BB or TGF-beta2.
71 amel matrix derivative and recombinant human platelet-derived growth factor-BB plus beta-tricalcium p
72 s 200 ng of bone morphogenetic protein-2 and platelet-derived growth factor-BB that were eluted over
73  growth factor, interleukin 6, angiopoietin, platelet-derived growth factor-BB, placental growth fact
74 matory cytokines interferon gamma, IL-1, and platelet-derived growth factor-BB, which are not produce
75 rleukin-1alpha, placental growth factor, and platelet-derived growth factor-BB.
76 ombination of lentiviral vectors, expressing platelet-derived growth factor beta (PDGF-B), constituti
77  (VWF), glutathione peroxidase 3 (GPX3), and platelet-derived growth factor beta (PDGFB).
78 sessed relationships between tau and soluble platelet-derived growth factor beta (sPDGFRbeta), a CSF
79 nds to the transmembrane domain (TMD) of the platelet-derived growth factor beta receptor (PDGFbetaR)
80 ing smooth muscle alpha-actin (alphaSMA) and platelet-derived growth factor beta receptor (PDGFbetaR)
81 le amino acid substitutions can activate the platelet-derived growth factor beta receptor or the eryt
82 d cells by forming a stable complex with the platelet-derived growth factor beta receptor transmembra
83                                      Soluble platelet-derived growth factor beta, an independent CSF
84 sions of fibrosis-related proteins including platelet-derived growth factor beta, fibronectin and col
85 nteract with the transmembrane domain of the platelet-derived growth factor beta-receptor and specifi
86  and cluster 4 (n=37; IL-8, IL-4, PDGF-beta [platelet-derived growth factor beta], IL-6, CCL11).
87                                              Platelet-derived growth factor-beta (PDGFB) is a mitogen
88 despite constituting a small fraction of the platelet-derived growth factor-beta (PDGFRbeta)(+) cell
89 nsforming growth factor-beta [TGF-beta], and platelet-derived growth factor-beta [PDGF-beta]) and blo
90  factor-D level, resulting in suppression of platelet-derived growth factor-beta activation and inhib
91 pe I collagen, matrix metalloprotease-1, and platelet-derived growth factor-beta.
92 in, tissue inhibitor of metalloproteinase 1, platelet-derived growth factor c, transforming growth fa
93 fibroblast haptotaxis on fibronectin but not platelet-derived growth factor chemotaxis.
94 odeling linked to maximal thrombospondin and platelet-derived growth factor D expression.
95 layed by transforming growth factor-beta and platelet-derived growth factor D in driving the recruitm
96 phages, T cells, and platelets and increased platelet-derived growth factor D, Pdgfrb, Itga2, and mat
97      In conclusion, our results suggest that platelet-derived growth factor-D is a target of itracona
98 ortantly, itraconazole significantly reduced platelet-derived growth factor-D level, resulting in sup
99 ein oxidation within cells, and suggest that platelet-derived growth factor-dependent "redoxosomes,"
100 es insight into the vascular architecture of platelet-derived growth factor-driven glioblastoma.
101                                              Platelet-derived growth factor, estrogen, and serotonin
102                                 We find that platelet-derived growth factor evokes transient oxidatio
103  cell neuroprotection, with factors from the platelet-derived growth factor family being the most pot
104 f activated T cells, epidermal growth factor/platelet-derived growth factor family members, Wnt/beta-
105           Two of these loci flank the canine platelet-derived growth factor gene, which affects bone
106 ulture self-assembled into microvessels, and platelet-derived growth factor had chemotactic effect on
107 on into brains of mice engineered to express platelet-derived growth factor in the central nervous sy
108 idence of and accelerated the development of platelet-derived growth factor -induced glioma in mice.
109  genetic deletion mutant in a mouse model of platelet-derived growth factor-induced malignant oligode
110                      In vitro, RR6 inhibited platelet-derived growth factor-induced SMC proliferation
111  factor, vascular endothelial growth factor, platelet-derived growth factor, interleukin (IL)-8, IL-1
112                                 Furthermore, platelet-derived growth factor may represent an independ
113                                          The Platelet Derived Growth Factor (PDGF) family of ligands
114                                              Platelet derived growth factor (PDGF) plays a pivotal ro
115           Many signaling pathways, including platelet- derived growth factor (PDGF)-AA/alphaalpha, ar
116                            Prostaglandin E2, platelet-derived growth factor (PDGF) AA, eotaxin, vascu
117                                              Platelet-derived growth factor (PDGF) acts through two c
118 to delineate the transcriptional response to platelet-derived growth factor (PDGF) and fibroblast gro
119 rum response factor (SRF) is induced by both platelet-derived growth factor (PDGF) and fibroblast gro
120        We find that fibroblasts treated with platelet-derived growth factor (PDGF) and prepolarized b
121                       Growth factors such as platelet-derived growth factor (PDGF) and the activation
122                           Expression of both platelet-derived growth factor (PDGF) and vascular endot
123 e involved in the lipopolysaccharide-induced platelet-derived growth factor (PDGF) and Wnt signaling
124 10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, admini
125                 Using these platforms, 10 pM platelet-derived growth factor (PDGF) are detected withi
126 agonist [WAY-200070 (WAY)] with TNF-alpha or platelet-derived growth factor (PDGF) followed by evalua
127 d apoptotic priming, we examined the role of platelet-derived growth factor (PDGF) in CAF priming for
128                                              Platelet-derived growth factor (PDGF) is a mitogen and c
129 rowth factors, the most representative being platelet-derived growth factor (PDGF) isoforms (PDGF-AA,
130 ied KCE method to an experimental model of a platelet-derived growth factor (PDGF) protein and its DN
131                                          The platelet-derived growth factor (PDGF) receptor (PDGFR) f
132                                        While platelet-derived growth factor (PDGF) receptor alpha (PD
133                                          The platelet-derived growth factor (PDGF) receptors (PDGFRs)
134                  Activation of the c-kit and platelet-derived growth factor (PDGF) receptors by autoc
135 ascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptors, has sin
136 roblast chemotaxis directed by a gradient of platelet-derived growth factor (PDGF) requires signaling
137 -of-function alterations leading to enhanced platelet-derived growth factor (PDGF) signaling are comm
138                                     Enhanced platelet-derived growth factor (PDGF) signaling in gliom
139           We show here that the receptor for platelet-derived growth factor (PDGF) signaling recruits
140                Inhibition of foxc1 perturbed platelet-derived growth factor (Pdgf) signaling, impairi
141            Mechanistically, we show that the platelet-derived growth factor (PDGF) signalling pathway
142 optical biosensing modulation by insulin and platelet-derived growth factor (PDGF) using the Aptamer-
143 ng a small interfering RNA (siRNA) targeting platelet-derived growth factor (PDGF) was used to allevi
144                                              Platelet-derived growth factor (PDGF), a potent mitogen
145 clotted wound by a concentration gradient of platelet-derived growth factor (PDGF), together with oth
146 s transforming growth factor-beta (TGFbeta), platelet-derived growth factor (PDGF), WNT and hedgehog
147                                     In vitro platelet-derived growth factor (PDGF)- and tumor necrosi
148                           Here, we show that platelet-derived growth factor (PDGF)-B/PDGF receptor be
149                                              Platelet-derived growth factor (PDGF)-BB belongs to a fa
150 EDE levels of VCAM-1, von Willebrand factor, platelet-derived growth factor (PDGF)-BB, angiopoietin-1
151 rotid artery, and VSMCs were pretreated with platelet-derived growth factor (PDGF)-BB.
152 angiogenic factors, friend of Gata 2 (FOG2), platelet-derived growth factor (PDGF)-beta, and phosphat
153                           We have identified platelet-derived growth factor (PDGF)-CC as a potent pro
154 e discovery of a novel ligand for PDGFRbeta, platelet-derived growth factor (PDGF)-DD, opened the pos
155                          Many tumors produce platelet-derived growth factor (PDGF)-DD, which promotes
156 d quiescent mesenchymal cell activation in a platelet-derived growth factor (PDGF)-dependent manner.
157                   Here, we present two novel platelet-derived growth factor (PDGF)-driven mouse model
158 ted knockdown of TRIM28 and TRIM27 inhibited platelet-derived growth factor (PDGF)-induced migration
159 ells (HASMCs); effect of Sema3E on basal and platelet-derived growth factor (PDGF)-induced proliferat
160         In damaged retina of flies and mice, platelet-derived growth factor (PDGF)-like signaling ind
161 or small interfering RNA knockdown decreased platelet-derived growth factor (PDGF)-mediated migration
162 c chambers that generate stable gradients of platelet-derived growth factor (PDGF).
163  highly sensitive and selective detection of platelet-derived growth factor (PDGF).
164  EC was uniformly inhibited by combined VEGF/platelet-derived growth factor (PDGF)/FGF receptor inhib
165 ular endothelial growth factor (VEGF) and 2) platelet-derived growth factor (PDGF-BB) in gingival cre
166 rCS3 binds the nerve growth factor (NGF) and platelet-derived growth factor (PDGF-BB), but the functi
167                                              Platelet-derived growth factors (PDGF) have an ambiguous
168 1 overexpression increases the expression of platelet-derived growth factor (PDGFB) in human pulmonar
169 sforming growth factor beta 1 (TGFbeta1) and platelet-derived growth factor (PDGFbetabeta) stimulatio
170                                              Platelet-derived growth factors (PDGFs) and their recept
171 cedures, including enamel matrix derivative, platelet-derived growth factor, platelet concentrates, a
172 factor], sCD40L [soluble CD40 ligand], PDGF [platelet-derived growth factor], RANTES [regulated on ac
173                                              Platelet Derived Growth Factor Receptor (PDGFR) signalin
174                                              Platelet derived growth factor receptor alpha (PDGFRalph
175                 Interstitial cells, known as platelet derived growth factor receptor alpha (PDGFRalph
176 ent of known imatinib targets including Abl, platelet derived growth factor receptor beta (PDGFRbeta)
177 razin-2(1H)-ones toward potent and effective platelet-derived growth factor receptor (PDGF-R) beta-in
178 ng fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR) and inte
179                                 It activates platelet-derived growth factor receptor (PDGFR) beta in
180 st growth factor receptor (FGFR) family, the platelet-derived growth factor receptor (PDGFR) family,
181                                              Platelet-derived growth factor receptor (PDGFR) senses e
182 YR mice had significantly reduced amounts of platelet-derived growth factor receptor (PDGFR), which i
183                                              Platelet-derived growth factor receptor (PDGFR)-alpha pl
184  platelet-derived growth factor BB (PDGF-BB)/platelet-derived growth factor receptor (PDGFR)-beta sig
185 isib also inhibited ALL proliferation in ABL/platelet-derived growth factor receptor (PDGFR)-mutant m
186    Anterograde transport mutants display low platelet-derived growth factor receptor (PDGFR)alpha lev
187 2), their coreceptor neuropilin1 (NRP1), and platelet-derived growth factor receptor (PDGFRalpha and
188 luded expected PI3K interactors, such as the platelet-derived growth factor receptor A (PDGFRA), as w
189       A fraction of Tppp3(+) cells expresses platelet-derived growth factor receptor alpha (Pdfgra).
190 GG), often in association with TP53 loss and platelet-derived growth factor receptor alpha (PDGFRA) a
191  Nkx2.2 can directly bind to the promoter of platelet-derived growth factor receptor alpha (Pdgfra) a
192 rized by an oncogenic mutation in the KIT or platelet-derived growth factor receptor alpha (PDGFRA) g
193          Here, we show an essential role for platelet-derived growth factor receptor alpha (Pdgfra) i
194 ncogene, receptor tyrosine kinase (KIT), and platelet-derived growth factor receptor alpha (PDGFRA) i
195 -oncogene receptor tyrosine kinase (KIT) and platelet-derived growth factor receptor alpha (PDGFRA) m
196 a CRISPR/Cas9 strategy identified guinea pig platelet-derived growth factor receptor alpha (PDGFRA) t
197 errations in FLT3, tyrosine kinase 2 (TYK2), platelet-derived growth factor receptor alpha (PDGFRA),
198 l cells of Cajal (ICC), and cells expressing platelet-derived growth factor receptor alpha (PDGFRalph
199                   In this study, we isolated Platelet-derived growth factor receptor alpha (PDGFRalph
200 ellular origin of new myelin by fate mapping platelet-derived growth factor receptor alpha (PDGFRalph
201  a poor prognosis and exhibit an increase in platelet-derived growth factor receptor alpha (PDGFRalph
202                                              Platelet-derived growth factor receptor alpha (PDGFRalph
203 that TAg expression reduces the abundance of platelet-derived growth factor receptor alpha (PDGFRalph
204               VEGF enhanced the viability of platelet-derived growth factor receptor alpha (PDGFRalph
205 l cells of Cajal (ICC), and cells expressing platelet-derived growth factor receptor alpha (PDGFRalph
206             Here, we investigate the role of platelet-derived growth factor receptor alpha (PDGFRalph
207 tion of H3.3 K27M cooperated with activating platelet-derived growth factor receptor alpha (PDGFRalph
208 f cone-driven photoresponses, were bred with platelet-derived growth factor receptor alpha (Pdgfralph
209                           Here, we show that platelet-derived growth factor receptor alpha (PDGFRalph
210                          Here we report that platelet-derived growth factor receptor alpha (PDGFRalph
211                                              Platelet-derived growth factor receptor alpha (PDGFRalph
212 many different signaling pathways, including platelet-derived growth factor receptor alpha (PDGFRalph
213 ssed in primitive stromal cells that express platelet-derived growth factor receptor alpha and Sca-1
214 SMCs), interstitial cells of Cajal (ICC) and platelet-derived growth factor receptor alpha positive (
215 more, oncogenic RAB35 is sufficient to drive platelet-derived growth factor receptor alpha to LAMP2-p
216                   IL1B stimulated subsets of platelet-derived growth factor receptor alpha(+) (PDGRFA
217 led alpha1 adrenoceptors (ARs) expression in platelet-derived growth factor receptor alpha(+) cells (
218     Populations of enteric neurons, ICC, and platelet-derived growth factor receptor alpha(+) cells w
219 ating with an increase in Il-6 expression in platelet-derived growth factor receptor alpha(+) mesench
220  differentiated alpha-smooth muscle actin(+)/platelet-derived growth factor receptor alpha(+)/CD44(+)
221 roblast growth factor receptors 1 through 4, platelet-derived growth factor receptor alpha, RET, and
222 atrix by increasing nonmuscle myosin II- and platelet-derived growth factor receptor alpha-mediated c
223 ntramuscular interstitial cells of Cajal and platelet-derived growth factor receptor alpha-positive c
224 ribution to vitreal bioactivity occurred via platelet-derived growth factor receptor alpha.
225 press the mesenchymal stem cell (MSC) marker platelet-derived growth factor receptor alpha; hence, we
226 N, resulting in increased phosphorylation of platelet-derived growth factor receptor and activation o
227  (NOXs), and oxidized SHP2 co-localizes with platelet-derived growth factor receptor and NOX1/4.
228  factor receptor, heat shock protein 90, and platelet-derived growth factor receptor as well as mutua
229 ling and functional screening identified the platelet-derived growth factor receptor b (PDGFRb) as bo
230 ranscriptional response to Mucorales reveals platelet-derived growth factor receptor B (PDGFRB) signa
231 n profiling, which revealed up-regulation of platelet-derived growth factor receptor beta (Pdgfrb) an
232 platelet-derived growth factor B (PDGFB) and platelet-derived growth factor receptor beta (PDGFRB), a
233                 Mesenchymal cells expressing platelet-derived growth factor receptor beta (PDGFRbeta)
234                                     Aberrant platelet-derived growth factor receptor beta (PDGFRbeta)
235 reased the catalytic loop phosphorylation of platelet-derived growth factor receptor beta (PDGFRbeta)
236 protein Sestrin 2 (Sesn2) as a suppressor of platelet-derived growth factor receptor beta (Pdgfrbeta)
237  MEFs show slower kinetics of ligand-induced platelet-derived growth factor receptor beta (PDGFRbeta)
238      Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor beta and can cro
239 mooth muscle cells (ISMC) with expression of platelet-derived growth factor receptor beta and progres
240  [GRCh37/hg19]; c.1685A>G) change within the platelet-derived growth factor receptor beta gene (PDGFR
241 in 2 (IGFBP-2), nerve growth factor (b-NGF), platelet-derived growth factor receptor beta polypeptide
242 erved in a laser-induced model of CNV that a platelet-derived growth factor receptor beta positive (P
243                 FDCs arise from perivascular platelet-derived growth factor receptor beta(+) precurso
244 gnificantly more NIK(+) ECs and perivascular platelet-derived growth factor receptor beta(+) preFDCs,
245 g., expression of alpha smooth muscle actin, platelet-derived growth factor receptor beta, desmin, vi
246        Glial fibrillary acid protein-Cre and platelet-derived growth factor receptor beta-Cre-mediate
247 l665Ala variant in PDGFRB, which encodes the platelet-derived growth factor receptor beta.
248  structure provides a first glimpse into how platelet-derived growth factor receptor ECD, upon ligand
249  vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibitor PTK787
250 he vascular endothelial growth factor (VEGF)/platelet-derived growth factor receptor inhibitor suniti
251 cular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitor, demon
252 ntibody or with small molecule inhibitors of platelet-derived growth factor receptor kinase or downst
253 ation and that it is selectively mediated by platelet-derived growth factor receptor signaling.
254              We recently discovered that the platelet-derived growth factor receptor(PDGFR)-beta sign
255 t epicardial-derived cells expressing PDGFR (platelet-derived growth factor receptor)-alpha were isol
256 tivation by a receptor activation loop (from platelet-derived growth factor receptor, a receptor tyro
257 lial cells and interstitial cells expressing platelet-derived growth factor receptor, alpha polypepti
258 ced RNA of epidermal growth factor receptor, platelet-derived growth factor receptor, and c-Met.
259 ing Smad3, epidermal growth factor receptor, platelet-derived growth factor receptor, signal transduc
260 xpressing cells, nestin-expressing cells and platelet-derived growth factor receptor-alpha (PDGFR-alp
261  progenitors expressing a mesodermal marker, platelet-derived growth factor receptor-alpha (PDGFRA),
262 ell lines revealed co-activation of HER2 and platelet-derived growth factor receptor-alpha (PDGFRalph
263 opulation (SP) phenotype, PECAM-1 (CD31) and platelet-derived growth factor receptor-alpha (PDGFRalph
264  could be identified with antibodies against platelet-derived growth factor receptor-alpha (PDGFRalph
265                                              Platelet-derived growth factor receptor-alpha (PDGFRalph
266  and flow sorted to isolate cells expressing platelet-derived growth factor receptor-alpha and exclud
267 ssion pattern, manifest in downregulation of platelet-derived growth factor receptor-alpha and recipr
268 rogenesis from precursor cells by inhibiting platelet-derived growth factor receptor-alpha cell endoc
269 to stabilize detrusor excitability involving platelet-derived growth factor receptor-alpha positive (
270            The presence and distributions of platelet-derived growth factor receptor-alpha(+) (PDGFRa
271 ild-type or constitutively activated PDGFRA (platelet-derived growth factor receptor-alpha) under con
272  cells coexpressing vimentin and PDGFRalpha (platelet-derived growth factor receptor-alpha), but gene
273  tyrosine kinases (RTKs) such as PDGFRalpha (platelet-derived growth factor receptor-alpha), which sh
274            Senescent cells were positive for platelet-derived growth factor receptor-alpha, vimentin,
275 alpha signaling was conditionally blocked in platelet-derived growth factor receptor-alpha-positive a
276 y, 2) connective tissue progenitor cells, 3) platelet-derived growth factor receptor-alpha-positive c
277          Connective tissue progenitor cells, platelet-derived growth factor receptor-alpha-positive c
278 nd dendritic spine formation through Rabex-5/platelet-derived growth factor receptor-beta (PDGFRbeta)
279                                              Platelet-derived growth factor receptor-beta (PDGFRbeta)
280 asculature followed by release of individual platelet-derived growth factor receptor-beta mural peric
281 iated capillary mural cell pericyte, soluble platelet-derived growth factor receptor-beta(8,18), and
282  a significant decrease in the expression of platelet-derived growth factor receptor-beta, a tyrosine
283  agent targeting VEGF receptors 1, 2, and 3, platelet-derived growth factor receptor-like protein (PD
284 eoglycan NG2, a co-receptor of integrins and platelet-derived growth factor receptor.
285          Our results identify the Snail-PTEN platelet-derived growth factor receptor/phosphatidylinos
286  structure of PDGFRbeta [a full-length human platelet-derived growth factor receptor], in complex wit
287 ne kinase activity of ABL1/BCR-ABL1 and KIT, platelet-derived growth factor receptors (PDGFRs), and t
288          Adipocyte progenitors (APs) express platelet-derived growth factor receptors (PDGFRs), PDGFR
289           Imatinib, a selective inhibitor of platelet-derived growth factor receptors, and anakinra,
290 of neuroprotective proteins and suggest that platelet-derived growth factor secretion in particular m
291 -vascular endothelial growth factor and anti-platelet-derived growth factor signaling.
292                                  Blockade of platelet-derived growth factor signalling with neutraliz
293 ively regulate G1 progression in response to platelet-derived growth factor stimulation.
294 y model, with positive correlation to PDGFB (platelet-derived growth factor subunit B) and MMP (matri
295 ophages, which then provide signals (such as platelet-derived growth factor) that drive beta-cell hyp
296 fically, we show how this transducer enables platelet-derived growth factor to trigger (in vitro) the
297  is a milieu of bioactive factors, including platelet derived growth factor, transforming growth fact
298  the hepatic stellate cell (HSC) activators, platelet-derived growth factor, transforming growth fact
299 SMILR was also altered by interleukin-1alpha/platelet-derived growth factor treatment, and HAS2 expre
300 ine kinase ligands (epidermal growth factor, platelet-derived growth factor, vascular endothelial gro

 
Page Top